Your English writing platform
Discover LudwigSuggestions(3)
Exact(5)
Dosing in this study was based on levels of serum creatinine, not on eGFR.
Appropriate dosing in this study (49 %) was much higher than Decloedt et al. (32 %), Sweileh et al. (26.42 %) and Salomon et al. (34%%) studies [ 14– 16].
The reduction in serum CCL13, CCL17, and IgE observed after lebrikizumab dosing in this study increases our confidence that the reduction in the LAR is indeed mediated, at least in part, through inhibition of Th2 inflammation via IL13 blockade.
The proportion of individuals that received bolus versus maintenance dosing in the two studies were remarkably similar (13.9% received bolus dosing in this study vs 12.6% and 49.3% received maintenance dosing vs 49.2%).
The NNH, based on discontinuations from the study, was higher in this trial (16) than in previous trials of 450 mg/day pregabalin in FM patients (in which it ranged from 9 to 11) [ 10, 13, 14], potentially influenced by the somewhat flexible, lower dosing in this study.
Similar(55)
Up to the highest dose in this study, the double junction or double peak electric field distribution is still preserved even after SCSRI.
No SCSRI has been observed yet for low-fluence neutron-irradiated MCZ Si detectors at the highest dose in this study (662 Mrad), but positive space charge is building up, and SCSRI is expected at higher doses.
The estimated effective doses in this study were higher than in most other publications.
However, the 1-h pain relief rate for the 3-mg SC dose in this study exceeded previous reports for the 6-mg SC dose at that timepoint (83% vs 70%) [14].
The "1.0" dose in this study corresponds to the approximate human dose and the final compound concentrations in yeast were: caffeine, 0.16 mg/gm yeast; lithium, 0.26 mg/gm; theobromine, 0.24 mg/gm; valproic acid, 0.20 mg/gm.
Although the product was shown to be immunogenic after two doses in this study, immunogenicity was not fully evaluated because the trial was stopped early due to unacceptable local reactogenicity.
Write better and faster with AI suggestions while staying true to your unique style.
Since I tried Ludwig back in 2017, I have been constantly using it in both editing and translation. Ever since, I suggest it to my translators at ProSciEditing.

Justyna Jupowicz-Kozak
CEO of Professional Science Editing for Scientists @ prosciediting.com